Revised Code of Washington
Chapter 69.04 - Intrastate Commerce in Drugs and Cosmetics.
69.04.570 - Introduction of new drug.

RCW 69.04.570
Introduction of new drug.

Except as permitted by chapter 69.77 RCW, no person shall introduce or deliver for introduction into intrastate commerce any new drug which is subject to section 505 of the federal act unless an application with respect to such drug has become effective thereunder. No person shall introduce or deliver for introduction into intrastate commerce any new drug which is not subject to section 505 of the federal act, unless (1) it has been found, by appropriate tests, that such drug is not unsafe for use under the conditions prescribed, recommended, or suggested in the labeling thereof; and (2) an application has been filed under this section of this chapter with respect to such drug: PROVIDED, That the requirement of subsection (2) of this section shall not apply to any drug introduced into intrastate commerce at any time prior to the enactment of this chapter or introduced into interstate commerce at any time prior to the enactment of the federal act: PROVIDED FURTHER, That if the director finds that the requirement of subsection (2) of this section as applied to any drug or class of drugs, is not necessary for the protection of the public health, he or she shall promulgate regulations of exemption accordingly.

[ 2017 c 212 § 10; 2012 c 117 § 338; 1945 c 257 § 75; Rem. Supp. 1945 § 6163-124.]

Structure Revised Code of Washington

Revised Code of Washington

Title 69 - Food, Drugs, Cosmetics, and Poisons

Chapter 69.04 - Intrastate Commerce in Drugs and Cosmetics.

69.04.001 - Statement of purpose.

69.04.002 - Introductory.

69.04.003 - "Federal act" defined.

69.04.004 - "Intrastate commerce."

69.04.005 - "Sale."

69.04.006 - "Director."

69.04.007 - "Person."

69.04.008 - "Food."

69.04.009 - "Drugs."

69.04.010 - "Device."

69.04.011 - "Cosmetic."

69.04.012 - "Official compendium."

69.04.013 - "Label."

69.04.014 - "Immediate container."

69.04.015 - "Labeling."

69.04.016 - "Misleading labeling or advertisement," how determined.

69.04.017 - "Antiseptic" as germicide.

69.04.018 - "New drug" defined.

69.04.019 - "Advertisement."

69.04.020 - "Contaminated with filth."

69.04.040 - Prohibited acts.

69.04.050 - Remedy by injunction.

69.04.060 - Criminal penalty for violations.

69.04.070 - Additional penalty.

69.04.080 - Avoidance of penalty.

69.04.090 - Liability of disseminator of advertisement.

69.04.100 - Condemnation of adulterated or misbranded article.

69.04.110 - Embargo of articles.

69.04.120 - Procedure on embargo.

69.04.130 - Petitions may be consolidated.

69.04.140 - Claimant entitled to sample.

69.04.150 - Damages not recoverable if probable cause existed.

69.04.160 - Prosecutions.

69.04.170 - Minor infractions.

69.04.180 - Proceedings to be in name of state.

69.04.370 - Right of access for inspection.

69.04.410 - Drugs—Adulteration by harmful substances.

69.04.420 - Drugs—Adulteration for failure to comply with compendium standard.

69.04.430 - Drugs—Adulteration for lack of represented purity or quality.

69.04.440 - Drugs—Adulteration by admixture or substitution of ingredients.

69.04.450 - Drugs—Misbranding by false labeling.

69.04.460 - Packaged drugs—Misbranding.

69.04.470 - Drugs—Misbranding by lack of prominent label.

69.04.480 - Drugs—Misbranding for failure to state content of habit forming drug.

69.04.490 - Drugs—Misbranding by failure to show usual name and ingredients.

69.04.500 - Drugs—Misbranding by failure to give directions for use and warnings.

69.04.510 - Drugs—Misbranding for improper packaging and labeling.

69.04.520 - Drugs—Misbranding for failure to show possibility of deterioration.

69.04.530 - Drugs—Misbranding by misleading representation.

69.04.540 - Drugs—Misbranding by sale without prescription of drug requiring it.

69.04.550 - Drugs exempt if in transit for completion purposes.

69.04.560 - Dispensing of certain drugs exempt.

69.04.565 - DMSO (dimethyl sulfoxide) authorized.

69.04.570 - Introduction of new drug.

69.04.580 - Application for introduction.

69.04.590 - Effective date of application.

69.04.600 - Denial of application.

69.04.610 - Revocation of denial.

69.04.620 - Service of order of denial.

69.04.630 - Drug for investigational use exempt.

69.04.640 - Court review of denial.

69.04.650 - Dispensing of certain drugs exempt.

69.04.660 - Federally licensed drugs exempt.

69.04.670 - Cosmetics—Adulteration by injurious substances.

69.04.680 - Cosmetics—Misbranding by false label, etc.

69.04.690 - Cosmetics—Misbranding by lack of prominent label.

69.04.700 - Cosmetics exempt if in transit for completion purposes.

69.04.710 - Advertisement, when deemed false.

69.04.720 - Advertising of cure of certain diseases deemed false.

69.04.730 - Enforcement, where vested—Regulations.

69.04.740 - Regulations to conform with federal regulations.

69.04.750 - Hearings.

69.04.761 - Hearing on proposed regulation—Procedure.

69.04.770 - Review on petition prior to effective date.

69.04.780 - Investigations—Samples—Right of entry—Verified statements.

69.04.790 - Owner may obtain part of sample.

69.04.800 - Access to records of other agencies.

69.04.810 - Access to records of intrastate carriers.

69.04.820 - Right of entry to factories, warehouses, vehicles, etc.

69.04.830 - Publication of reports of judgments, orders and decrees.

69.04.840 - Dissemination of information.

69.04.850 - Construction—1945 c 257.

69.04.860 - Effective date of chapter—1945 c 257.

69.04.880 - Civil penalty.